TISANA KELEMATA ERBE OS 80G

TISANA KELEMATA powder

active ingredients

100 g contain: Active ingredient: Seine leaves g 51,28 Aromatizer and excipients: Gramigna rizoma g 12,83 Guaiaco wood g 6,41 Issopo leaves g 6,41 Parietaria leaves g 6,41 Peppermint leaves g 5,13 Salsapariglia roots g 6,41 Star anise fruit g 2,56 Melissa summit g 2,56

Excellent

Gramigna, sheath, issopo, parietaria, peppermint, salsapariglia, star anise and melissa.

Therapeutic indications

Short-term treatment of occasional constipation.

Contraindications

Hypersensitivity to the active ingredient or any of the excipients. Laxatives are contraindicated in subjects with acute or unknown abdominal pain, nausea or vomiting, obstruction or intestinal stenosis, rectal bleeding of unknown origin, severe state of dehydration. Generally contraindicated during pregnancy and nursing (see p. 4.6). Contraindicated in children under 10 years of age.

Population

The correct dose is sufficient to produce an easy evacuation of soft feces. It is advisable to initially use the minimum doses provided. When necessary, the dose may be increased, but never exceed the maximum indicated. Preferably in the evening. Laxatives must be used as frequently as possible and for no more than seven days. Use for longer periods requires the doctor’s prescription after adequate evaluation of the individual case. Eating together with an adequate amount of water. A fluid-rich diet promotes the effect of the medicine. Take the prepared herbal tea in accordance with the following steps: put in a cup of tea 1-2 teaspoons of Tisana Kelemata; pour over boiling water and leave infusion for 10-15 minutes, then school. Do not exceed the recommended doses.

Conservation

Store the product below 30°C.

Warnings

Warnings. Laxative abuse (frequent or prolonged use or excessive doses) can cause persistent diarrhea resulting in water loss, mineral salts (especially potassium) and other essential nutrients. In the most serious cases, dehydration or hypopotassiemia may occur, which may result in cardiac or neuromuscular dysfunctions, especially in the case of contemporary treatment with cardiac glycosides, diuretics or corticosteroids. The abuse of laxatives, especially those of contact (stimulating laxatives) can cause dependence (and, therefore, possible need to gradually increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atonia). Precautions for use. In children under 12 years, the medicine can only be used after consulting the doctor. Treatment of chronic or recurring constipation always requires medical intervention for diagnosis, prescription of drugs and surveillance during therapy. Consult your doctor when the need for laxative comes from a sudden change of previous intestinal habits (frequency and evacuation characteristics) that lasts for more than two weeks or when the use of laxative fails to produce effects. You should also consult your doctor before using the medicine.

Interactions

Laxatives can reduce the time of stay in the intestine, and, therefore, the absorption of other drugs administered at the same time by mouth. Avoid, then, at the same time ingest laxatives and other drugs: after taking a medicine let spend a range of at least two hours before taking laxative. Milk or antacids may change the effect of the medicinal product; let spend a range of at least one hour before taking the laxative.

Effects

Occasionally: isolated crampiform pain or abdominal colic pain, more frequent in cases of severe constipation. With the use of the product, the urine sometimes color slightly in yellow-brown or red. This coloration is simply due to the presence in the urine of components of the bucket and is not clinically significant.

Overdosing

Excessive doses can cause abdominal pain and diarrhea; the consequent losses of liquids and electrolytes must be replaced. See also the paragraph “Special warnings and precautions for use” about the abuse of laxatives.

There are no adequate and well-controlled studies on the use of pregnant or nursing medicine. Therefore the medicinal product must be used only in case of need, under the direct control of the doctor, after evaluating the expected benefit for the mother in relation to the possible risk for the fetus or for the infant.

Source: Farmadati